The neurobiology of nicotine addiction: Clinical and public policy implications

Journal of Drug Issues

Volumn 39, Issue 2, 2009, Pages 417-442

  Gardner, Paul D ^a,b   Tapper, Andrew R ^b   King, Jean A ^b,c   Difranza, Joseph R ^b   Ziedonis, Douglas M ^b  

^a Department of Psychiatry

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Center for Comparative Neurolmaqina

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68949202591     PISSN: 00220426     EISSN: None     Source Type: Journal    
DOI: 10.1177/002204260903900211     Document Type: Article

References (104)

1. Abreu-Villaca, Y.A., Seidler, F.J., Qiao, D., Tate, C.A., Cousins, M.M., Thillai, I., & Slotkin, T.A. 2003 Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: Critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology, 28,1935-1949
2. American Psychiatric Association 2000 Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association.
3. Arneric, S.P., Holladay, M., & Williams, M. 2007 Neuronal nicotine receptors: A perspective on two decades of drug discovery research. Biochemical Pharmacology, 74, 1092-1101.
4. Benowitz, N.L. 2008 Neurobiology of nicotine addiction: Implications for smoking cessation treatment. American Journal of Medicine, 121, S3-S10.
5. Berrettini, W., Yuan, X., Tozzi, F., Song, K., Francks, C, Chilcoat, H., Waterworth, D., Muglia, P., & Mooser, V. 2008 α-5/α-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Molecular Psychiatry, 13, 368-373.
6. Bevins, R.A., & Besheer, J. 2001 Individual differences in rat locomotor activity are diminished by nicotine through stimulation of central nicotinic acetylcholine receptors. Physiology & Behavior, 72, 237-244.
7. Boulter, J., O'Shea-Greenfield, A., Duvoisin, R.M., Connolly, J.G., Wada, E., Jensen, A., Gardner, P.D., Ballivet, M., Deneris, E.S., McKinnon, D., & Heinemann, S., & Patrick, J. 1990 Alpha 3, alpha 5, and beta 4: Three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. Journal of Biological Chemistry, 265(8), 4472-4482.
8. Brewster, T., Farentinos, C., & Ziedonis, D. 2002. Response: The neurobiological model in community treatment programs. Scientific Practices & Perspectives, 1(1), 21.
9. Brody, A.L., Mandelkern, M.A., London, E.D., Olmstead, R.E., Farahi, J., Scheibal, D., Jou, J., Allen, V., Tiongson, E., Chefer, S.I., Koren, A.O., & Mukhin, A.G. 2006 Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors. Archives of General Psychiatry, 63(8), 907-915
10. Carboni, E., Bortone, L., Giua, C, & Di Chiara, G. 2000 Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug and Alcohol Dependence, 55(1-2), 93-102.
11. Cerny, E.H., & Cerny, T. 2008 Anti-nicotine abuse vaccines in the pipeline: An update. Expert Opinion on Investigational Drugs, 17(5), 691-696.
12. Champtiaux, N., & Changeux, J.P. 2004 Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. Progress in Brain Research, 145, 235-251.
13. Chi, H., & de Wit, H. 2003 Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcoholism-Clinical and Experimental Research, 27(5), 780-786.
14. Corrigall, W.A., & Coen, K.M. 1991 Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology, 107, 171-176.
15. Corrigall, W.A., Franklin, K.B., Coen, K.M., & Clarke, P.B. 1992 The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology, 107, 285-289.
16. Damaj, M.I., Kao, W., & Martin, B.R. 2003 Characterization of spontaneous and precipitated nicotine withdrawal in the mouse. Journal of Pharmacological and Experimental Therapeutics, 307(2), 526-534.
17. Dani, J.A. 2001 Overview of nicotinic receptors and their roles in the central nervous system. Biological Psychiatry, 49(3), 166-174
18. Dani, J.A., & Bertrand, D. 2007 Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699-729.
19. Dasgupta, P., & Chellappan, S.P. 2006 Nicotine-mediated cell proliferation and angiogenesis. Cell Cycle, 5,2324-2328.
20. DiFranza, J.R., Savageau, J.A., Fletcher, K., O'Loughlin, J., Pbert, L., Ockene, J.K., McNeill, A.D., Hazelton, J., Friedman, K., Dussault, G., Wood, C, & Wellman, R.J. 2007a Symptoms of tobacco dependence after brief intermittent use-The development and assessment of nicotine dependence in youth-2. Archives of Pediatrics and Adolescent Medicine, 161(7), 704-710
21. DiFranza, J.R., Savageau, J.A., Fletcher, K., Pbert, L., O'Loughlin, J., McNeill, A.D., Ockene, J.K., Friedman, K., Hazelton, J., Wood, C, Dussault, G., & Wellman, R.J. 2007b Susceptibility to nicotine dependence: the Development and Assessment of Nicotine Dependence in Youth-2. Pediatrics, 120, e974-e83.
22. DiFranza, J. & Ursprung, W. 2008 The latency to the onset of nicotine withdrawal: A test of the Sensitization-Homeostasis Theory. Addictive Behaviors, 33,1148-1153
23. DiFranza, J. R., & Wellman, R.J. 2005 A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: Integrating the clinical and basic science literature. Nicotine & Tobacco Research, 7, 9-26.
24. DiFranza, J. R., & Wellman, R.J. 2005 A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: Integrating the clinical and basic science literature. Nicotine & Tobacco Research, 7, 9-26.
25. DiFranza, J.R., & Wellman, R.J. 2007 Sensitization to nicotine: How the animal literature might inform future human research. Nicotine & Tobacco Research, 9, 9-20.
26. Doll, R., Peto, R., Boreham, J., & Sutherland, I. 2004 Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328, 1519.
27. Drago, J., McColl, C.D., Horne, M.K., Finkelstein, D.I., & Ross, S.A. 2003 Neuronal nicotinic receptors: Insights gained from gene knockout and knockin mutant mice. Cellular and Molecular Life Sciences, 60, 1267-1280.
28. Elgoyhen, A.B., Vetter, D.E., Katz, E., Rothlin, C.V., Heinemann, S.F., & Boulter, J. 2001 a10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Science, U.S.A., 98(6), 3501-3506.
29. Exley, R., Clements, M.A., Hartung, H., Mcintosh, J.M., & Cragg, S.J. 2007 Alpha-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology, 33, 2158-2166
30. Federal Aviation Authority 2008 Advisory to pilots and air traffic controllers banning varenicline use. May 21, 2008.
31. Food and Drug Administration. 2007 Early communication about an ongoing safety review of varenicline. November 20, 2007.
32. Food and Drug Administration 2008 FDA issues public health advisory on Chantix®. February 1, 2008.
33. Fornasari, D., Battaglioli, E., Terzano, S., & Clementi, F. 1998 Transcriptional regulation of neuronal nicotinic receptor subunit genes. In Neuronal nicotinic receptors: Pharmacology and therapeutic opportunities. Arneric, S.P. & Brioni, J.D. (Eds.), Wiley-Liss, Inc.
34. Franklin, T.R., Wang, Z., Wang, J., Sciortino, N., Harper, D., Li, Y., Ehrman, R., Kampman, K., O'Brien, C.P., Detre, J.A., & Childress, A.R. 2007 Limbic activation to cigarette smoking cues independent of nicotine withdrawal: A perfusion fMRI study. Neuropsychopharmacology., 21(11), 2301-2309.
35. Fung, Y.K., Schmid, M.J., Anderson ,T.M., & Lau, Y.S. 1996 Effects of nicotine withdrawal on central dopaminergic systems. Pharmacology, Biochemistry and Behavior, 53(3), 635-640.
36. Gahring, L.C., & Rogers, S.W. 2006 Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. American Association of Pharmaceutical Scientists Journal, 7, E885-E894.
37. George, T.P. 2007 Medication Treatments for Nicotine Dependence. Taylor & Francis: Boca Raton.
38. Gervais, A., O'Loughlin, J., Meshefedjian, G., Bancej, C, Tremblay, M. 2006 Milestones in the natural course of cigarette use onset in adolescents. Canadian Medical Association Journal, 175(3), 255-261
39. Gonzales, D., Rennard, S.I., Nides, M., Oncken, C., Azoulay S., & Billing, C.B. 2006 Varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. Journal of the American Medical Association, 296, 47-55.
40. Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. 2007 Heterogeneity and complexity of native brain nicotinic receptors. Biochemical Pharmacology, 74, 1102-1111.
41. Grady, S.R., Salminen, O., Laverty, D.C., Whiteaker, P., Mcintosh, J.M., Collins, A.C., & Marks, M.J. 2007 The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochemical Pharmacology, 74(8), 1235-1246.
42. Hahn, B., Stolerman, I.P., & Shoaib, M. 2000 Kappa-opioid receptor modulation of nicotine-induce behavior. Neuropharmacology, 39, 2848-2855.
43. Harris, R.A. 1999 Ethanol actions on multiple ion channels: Which are important? Alcoholism-Clinical and Experimental Research, 23(10), 1563-1570.
44. Hensley, S. 2008 As bad news mounts, Chantix® prescriptions crumble. Wall Street Journal May 30,2008.
45. Hildebrand, B.E., Nomikos, G.G., Hertel, P., Schilstrom, B., & Svensson, T.H. 1998 Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome. Brain Research,779(1-2), 214-225.
46. Hildebrand, B.E., Panagis, G., Svensson, T.H., & Nomikos, G.G. 1999 Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: Role of nicotinic receptors in the ventral tegmental area. Neuropsychopharmacology, 21(4), 560-574.
47. Hughes, J.R. 2007 Effects of abstinence from tobacco: Valid symptoms and time course. Nicotine & Tobacco Research, 9(3), 315-327.
48. Jackson, K.J., Martin, B.R., Changeux, J.P., & Damaj, M.I. 2008 Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. Journal of Pharmacological and Experimental Therapeutics, 325(1), 302-312.
49. Kalivas, P.W., Sorg, B.A., & Hooks, M.S. 1993 The pharmacology and neural circuitry of sensitization to psychostimulants. Behavioral Pharmacology, 4(4), 315-334.
50. Kandel, D., Hu, M.C., Grieisler, P., & Schaffran, C. 2007 On the development of nicotine dependence in adolescence. Drug & Alcohol Dependence, 91,26-39.
51. Kenny, P.J., & Markou, A. 2001 Neurobiology of the nicotine withdrawal syndrome. Pharmacology, Biochemistry and Behavior, 70(4), 531-549.
52. King, J., Shields, J., DiFranza, J., & Rane, P. 2009 Nicotine-induced behavioral sensitization in normal and ADHD rats. Unpublished personal communication.
53. Kita, T., Okamoto, M., & Nakashima, T. 1992 Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats. Life Sciences, 50(8), 583-590.
54. Larsson, A., Svensson, L., Soderpalm, B., & Engel, J.A. 2002 Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol, 28, 157-167.
55. Laviolette, S.R., & van der Kooy, D. 2004 The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nature Reviews Neuroscience, 5(1), 55-65.
56. Li, Z., DiFranza, J.R., Wellman, R.J., Kulkarni, P., & King, J.A. 2008 Imaging brain activation in nicotine-sensitized rats. Brain Research, 11 (99), 91-99.
57. Lupica, C.R, & Brodie, M.S. 2006 Queer Currents, Steady Rhythms, and Drunken DA Neurons. Focus on Hyperpolarization-Activated Cation Current (Ih) Is an Ethanol Target in Midbrain Dopamine Neurons of Mice. Journal of Neurophysiology, 95, 585-586
58. Lustig, L.R., Peng, H., Hiel, H., Yamamoto, T., & Fuchs, P.A. 2001 Molecular cloning and mapping of the human nicotinic acetylcholine receptor alpha10 (CHRNA10). Genomics, 73(3), 272-283.
59. Malin, D.H., Lake, J.R., Carter, V.A., Cunningham, J.S., Hebert, K.M., Conrad, D.L., & Wilson, O.B. 1994 The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat. Psychopharmacology, 115(1-2), 180-184.
60. Malin, D.H., Lake, J.R., Carter, V.A., Cunningham, J.S., & Wilson, O.B. 1993 Naloxone precipitates nicotine abstinence syndrome in the rat. Psychopharmacology, 112, 339-342.
61. Marks, M.J., Meinerz, N.M., Drago, J., & Collins, A.C. 2007 Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H] epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine. Neuropharmacology, 53(3), 390-405.
62. Marks, M.J., Whiteaker, P., Calcaterra, J., Stitzel, J.A., Bullock, A.E., Grady, S.R., Picciotto, M.R., Changeux, J.P., & Collins, A.C. 1999 Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. Journal of Pharmacological and Experimental Therapeutics, 289(2), 1090-1103.
63. Marubio, L.M., Gardier, A.M., Durier, S., David, D., Klink, R., Arroyo-Jimenez, M.M., Mcintosh, J.M., Rossi, F., Champtiaux, N., Zoli, M., & Changeux, J.P. 2003 Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors. European Journal of Neuroscience, 17(1), 1329-1337.
64. Maskos, U., Molles, B.E., Pons, S., Besson, M., Guiard, B.P., Guilloux, J.P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., Dufour, N., Cloez-Tayarani, I., Bemelmans, A.P., Mallet, J., Gardier, A.M., David, V., Faure, P., Granon, S., & Changeux, J.P. 2005 Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436(7047), 103-107.
65. Maurer, P., Jennings, G.T., Willers, J., Rohner, J., Lindman, Y, Roubicek, K., Renner, W.A., Muller, P., & Bachmann, M.F. 2005 A therapeutic vaccine for nicotine dependence: Preclinical efficacy, and Phase I safety and immunogenicity. European Journal of Immunology, 35(1), 2031-2040.
66. McBride, D., Barrett, S.P., Kelly, J.T., Aw, A., & Dagher, A. 2006 Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: An fMRI study. Neuropsychopharmacology, 31(12), 2728-2738.
67. McCallum, S.E., Collins, A.C, Paylor, R., & Marks, M.J. 2006 Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology, 184(3-4), 314-327.
68. McClernon, F.J., Hiott, F.B., Liu, J., Salley, A.N., Behm, F.M., & Rose, J.E. 2007 Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: Results of a preliminary functional magnetic resonance imaging study. Addiction Biology, 12(3-4), 503-512.
69. Minna, J.D. 2003 Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. Journal of Clinical Investigation, 111(1), 31-33.
70. Moore, T.J., Cohen, M.R., & Furberg, CD. 2008 Strong safety signal seen for new varenicline risks. The Institute for Safe Medication Practices QuarterWatch, May 21, 2008,1-11.
71. Nestler, E.J. 2001 Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience, 2, 119-128
72. Nides, M. 2008 Update on pharmacologic options for smoking cessation treatment. American Journal of Medicine, 121, S20-S31.
73. Panagis, G., Nisell, M., Nomikos, G.G., Chergui, K., & Svensson, T.H. 1996 Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Research, 730(1-2), 133-142.
74. Picciotto, M.R., Zoli, M., Lena, C, Bessis, A., Lallemand, Y., Le Novere, N., Vincent, P., Pich, E.M., Brulet, P., & Changeux, J.P. 1995 Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature, 374(6517), 65-67.
75. Picciotto, M.R., Zoli, M., Rimondini, R., Lena, C, Marubio, L.M., Pich, E.M., Fuxe, K.., & Changeux, J.P. 1998 Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173-177.
76. Pidoplichko, V.I., DeBiasi, M., Williams, J.T., & Dani, J.A. 1997 Nicotine activates and desensitizes midbrain dopamine neurons. Nature, 390(6658), 401-404.
77. Pierce, R.C., & Kalivas, P.W. 1997 A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research Reviews, 25(2), 192-216.
78. Popkin, M.K. 2008 Exacerbation of recurrent depression as a result of treatment with varenicline. American Journal of Psychiatry, 165(6), 774.
79. Post, R.M. 1980 Intermittent versus continuous stimulation: Effect of time interval on the development of sensitization or tolerance. Life Science, 26(16), 1275-1282.
80. Rose. J., Behm. F., & Westman, E. 2001 Acute effects of nicotine and mecamylamine on tobacco withdrawal symptoms, cigarette reward and ad lib smoking. Pharmacology Biochemistry and Behavior, 68, 187-197
81. Salas, R., Main, A., Gangitano, D., & De Biasi, M. 2007 Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit. Neuropharmacology, 53(7), 863-869.
82. Salminen, O., Drapeau, J.A., Mcintosh, J.M., Collins, A.C., Marks, M.J., & Grady, S.R. 2007 Pharmacology of alpha-conotoxin Mil-sensitive subtypes of nicotinic acetylcholine receptors isolated by breeding of null mutant mice. Molecular Pharmacology, 71(6), 1563-1571.
83. Salminen, O., Murphy, K.L., Mcintosh, J.M., Drago, J., Marks, M.J., Collins, A.C., & Grady, S.R. 2004 Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology, 65(6), 1526-1535.
84. Schlaepfer, I.R., Hoft, N.R., Collins, A.C., Corley, R.P., Hewitt, J.K., Hopfer, C.J., Lessern, J.M., McQueen, M.B., Hyun Rhee, S., & Ehringer, M.A. 2008 The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biological Psychiatry, 63, 1039-1046.
85. Schochet, T.L., Kelley, A.E., & Landry, C.F. 2005 Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. Neuroscience, 135( 1), 285-297.
86. Schultz, W. 2004 Neural coding of basic reward terms of animal learning theory, game theory, microeconomics and behavioural ecology. Current Opinion in Neurobiology, 14(2), 139-147.
87. Scragg, R., Wellman, R.J., Laugesen, M., & DiFranza, J.R. 2008 Diminished autonomy over tobacco can appear after the first cigarette. Addictive Behaviors, 33, 689-698
88. Shim, I., Avaid, J.I., Wirtshafter, J.D., Jang, S.Y., Shin, K.H., Lee, H.J., Chung, Y.C., & Chun, B.G. 2001 Nicotine-induced behavioral sensitization is associated with extracellular dopamine release and expression of c-Fos in the striatum and nucleus accumbens of the rat. Behavioral Brain Research, 121(1-2), 137-147.
89. Slotkin, T., MacKillop, E., Rudder, C, Ryde, I., Tate, C, & Seidler, F. 2007 Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: Indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at six months of age. Neuropsychopharmacology, 32, 1082-1097
90. Smolka, M.N., Biihler, M., Klein, S., Zimmermann, U., Mann, K., Heinz, A., & Braus, D.F. 2006 Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology, 754(3-4), 577-588.
91. Suzuki, T., Ise, Y., Tsuda, M., Maeda, J., & Misawa, M. 1996 Mecamylamine-precipitated nicotine-withdrawal aversion in rats. European Journal of Pharmacology, 314(3), 281-284.
92. Tapper, A.R., McKinney, S.L., Marks, M., & Lester, H.A. 2007 Nicotine responses in hypersensitive and knockout alpha 4 mice account for tolerance to both hypothermia and locomotor suppression in wild-type mice. Physiological Genomics, 31(3), 422-428.
93. Tapper, A.R., McKinney, S.L., Nashmi, R., Schwarz, J., Deshpande, R, Labarca, C, Whiteaker, P., Marks, M.J., Collins, A.C., & Lester , H.A. 2004 Nicotine activation of alpha4* receptors: Sufficient for reward, tolerance, and sensitization. Science, 306,1029-1032.
94. Uhl, G.R., Liu, Q.-R., Drgon, T., Johnson, C, Walther, D., Rose, J.E., David, S.P., Niaura, R., & Lerman, C. 2008 Molecular genetics of successful smoking cessation: Convergent genome-wide association study results. Archives of General Psychiatry, 65(6), 683-693.
95. Volk, H.E., Scherrer, J.F., Bucholz, K.K., Todorov, A., Hearth, A.C., Jacob, T., & True, W.R. 2007 Evidence for specificity of transmission of alcohol and nicotine dependence in an offspring of twins design. Drug and Alcohol Dependence, 87(2-3), 225-232
96. Volkow, N.D., Wang, G.J., Fowler, J.S., & Telang, F. 2008 Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philosophical Transactions of the Royal Society of London B-Biological Sciences, 363(1507), 3191-3200
97. Wada, E., Wada, K., Boulter, J., Deneris, E., Heinemann, S., Patrick, J., & Swanson, L.W. 1989 Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat. Journal of Comparative Neurology, 284(2), 314-335.
98. Wagena, E.J., de Vos, A., Horwith, G., & van Schayck, C.P. 2008 The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: Results of a randomized, placebo-controlled phase 1/2 trial. Nicotine & Tobacco Research, 10(1), 213-218.
99. Wellman, R.J., DiFranza, J.R., Savageau, J.A., Godiwala, S., Savageau, N., Friedman, K., & Hazelton, J. 2006 The effect of abstinence on cigarette consumption upon the resumption of smoking. Addictive Behaviors, 31, 711-716
100. Xue, Y., & Domino, E.F. 2008 Tobacco/nicotine and endogenous brain opioids. Prog. Neuro-Progress in Neuro-psychopharmacology & Biological Psychiatry. Elsevier, in press.
101. Ziedonis, D.M. 2004 Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrum, 9( 12), 892-904.
102. Ziedonis, D.M. & Williams, J. 2003 Addressing Tobacco Use in Mental Health and Addiction Settings. Psychiatric Annals 33(1), 425-426.
103. Zoli, M., Le Novere, N., Hill, J.A., Jr., & Changeux, J.P. 1995 Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. Journal of Neuroscience, 15(3 Pt 1), 1912-1939.
104. Zubieta, J.K., Heitzeg, M.M., Xu, Y., Koeppe, R.A., Lisong, N., Guthrie, S., & Domino, E.F. 2005 Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. American Journal of Psychiatry, 162(3), 567-577.